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ABSTRACT
Introduction: Approximately 700 000 people in the
UK have dementia, rising to 1.2 million by 2050; one-
third of people aged over 65 will die with dementia.
Good end-of-life care is often neglected, and detailed
UK-based research on symptom burden and needs is
lacking. Our project examines these issues from
multiple perspectives using a rigorous and innovative
design, collecting data which will inform the
development of pragmatic interventions to improve
care.
Methods and analysis: To define in detail symptom
burden, service provision and factors affecting care
pathways we shall use mixed methods: prospective
cohort studies of people with advanced dementia and
their carers; workshops and interactive interviews with
health professionals and carers, and a workshop with
people with early stage dementia. Interim analyses of
cohort data will inform new scenarios for workshops
and interviews. Final analysis will include cohort
demographics, the symptom burden and health service
use over the follow-up period. We shall explore the
level and nature of unmet needs, describing how
comfort and quality of life change over time and
differences between those living in care homes and
those remaining in their own homes. Data from
workshops and interviews will be analysed for thematic
content assisted by textual grouping software. Findings
will inform the development of a complex intervention
in the next phase of the research programme.
Ethics and dissemination: Ethical approval was
granted by National Health Service ethical committees
for studies involving people with dementia and carers
(REC refs. 12/EE/0003; 12/LO/0346), and by university
ethics committee for work with healthcare
professionals (REC ref. 3578/001). We shall present
our findings at conferences, and in peer-reviewed
journals, prepare detailed reports for organisations
involved with end-of-life care and dementia, publicising
results on the Marie Curie website. A summary of the
research will be provided to participants if requested.
INTRODUCTION
Approximately 700 000 people in the UK have
dementia. This will rise to around 840 000 by
2026 and 1.2 million by 2050.1 One-third of
people aged over 65 in the UK will die while
suffering from dementia.2 In 2005, it was esti-
mated that 24.3 million people worldwide had
dementia with 4.6 million new cases occurring
every year, mostly in developing countries.
People with dementia have signiﬁcantly
increased death rates3 and even minor cogni-
tive impairment is a strong independent pre-
dictor of mortality.4 Dementia typically involves
a long, gradual decline in cognition, behaviour
and function. In this research we consider
ARTICLE SUMMARY
Article focus
▪ This article describes a mixed methods study to
gain an in-depth understanding of the end-of-life
experience of people with advanced dementia
and their carers.
Key messages
▪ By 2050, it is anticipated that one-third of people
aged over 65 will die with dementia.
▪ This research will provide evidence from multiple
perspectives on the main components of good
end-of-life care that are currently often neglected
in dementia.
Strengths and limitations of this study
▪ To our knowledge the quantitative data from the
cohort studies will be the first of this nature to
be collected in the UK.
▪ The workshops and interactive interviews will
provide richness and background to this quanti-
tative data, allowing it to be placed in the context
of a complex health and social care system.
▪ This research does not address the palliative and
end-of-life needs of those dying at earlier stages
of dementia from other comorbid conditions.
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people in the advanced stages of this disease who are
approaching death.
Challenges
Essential components of good end-of-life care are often
neglected in dementia, and referral to palliative care is
rare.5 Fewer than 1% of hospice patients in Europe have a
neurological diagnosis.6 Despite concerns about prognos-
tic uncertainty, behavioural problems or communication
difﬁculties,7 8 most symptoms such as pain or difﬁculties
swallowing could be managed with good generalist care.9
Providing care at home is an aim of the UK Government’s
End of Life Care Strategy; while beneﬁtting patients and
carers it aims to save National Health Service (NHS) costs
by avoiding acute hospital admissions.9 A recent National
Audit Ofﬁce report indicated that about 50% of care
home residents who died in hospital could have died at
home.10 In dementia, research has tended to emphasise
speciﬁc interventions such as pain control, or the with-
drawal of care, for example, not prescribing antibiotics or
withdrawing feeding.11–15 However, good care may require
a more rounded (but cost effective) palliative approach,
tailored individually to address patient symptoms and the
needs of informal carers, particularly in the terminal
phase and in bereavement.
Clinical picture
Advanced dementia can be deﬁned using the Functional
Assessment Staging Scale (FAST) level 7 and above16: the
person cannot dress themselves, is doubly incontinent and
speaks only a few words. With a median survival of 1.3 years,
life expectancy is similar to metastatic breast cancer.17 A
retrospective UK study of the last year of life showed that
symptom burden and care needs were comparable to those
in cancer; in particular 64% of dementia patients experi-
enced pain (compared with 59% with cancer), dyspnoea
(46%), pressure sores (39%) and difﬁculty swallowing or
loss of appetite (86%).17 18 However, detailed research to
deﬁne the symptom burden and needs of people with
advanced dementia at the end-of-life and their informal
carers has not been conducted in the UK.
Care Of Memory Problems in Advanced Stages: Improving
Our Knowledge programme
In this paper we describe the ﬁrst 12-month phase of
the three-year Care Of Memory Problems in Advanced
Stages: Improving Our Knowledge programme which
takes place in the UK. We shall use mixed methods to
collect ﬁne-grained qualitative and quantitative data on
the experiences of people with advanced dementia and
their carers as death approaches and in bereavement.
Findings will inform the development of a new model of
care (intervention) in the next phase of this research
(ﬁgure 1). This work responds to the UK government
initiatives to provide rigorous evidence to improve the
experience of people with dementia and their carers
around death and in bereavement.9 19 20 The research has
been adopted onto the portfolios of the National Institute
for Health Research Clinical Research Network (NIHR
CRN)—Primary Care Research Network (PCRN) (Refs.
12621; 12623) and the Dementia and Neurodegenerative
Diseases Research Network (DeNDRoN).
METHODS
Aim
To understand the end-of-life experience of people with
dementia and their carers and to generate information
on how this could be improved.
Objectives
1. In people with advanced dementia we will study in depth
their clinical symptom burden and health and social care
needs, and pathways of care as the end-of-life approaches.
2. In informal family carers to understand in depth
their needs and experiences in the period before
bereavement and in the months after their loss.
3. To gather views from professional and informal
carers on how care could be improved.
Literature update
We shall begin by updating existing reviews of the inter-
national literature on end-of-life interventions for
people with advanced dementia and their carers and
carer bereavement.5 12 21 22
Cohort studies (quantitative data)
We shall conduct prospective cohort studies of people
with advanced dementia and their carers.
People with advanced dementia
Study population
With assistance from the PCRN we shall recruit 100 people
with advanced dementia, 50 in patient-carer dyads, 70%
residing in care homes and 30% in their own homes1 from
10 boroughs in London, UK. We shall purposively select
10–20 care homes served by general practices (GP) linked
to the PCRN that are representative of variations in quality,
number of beds and type of ownership.
We will include people over 65 years of age with a clin-
ical diagnosis of dementia (DSM-IV criteria),23 at the
FAST grade 7c and above16 (unable to walk, all intelli-
gible speech is lost and doubly incontinent). As people
with advanced dementia will be unable to give informed
consent; we will gain assent from a carer (‘personal con-
sultee’) or professional consultee who is able to give
assent. We will not include those who indicate either ver-
bally or non-verbally that they do not wish to participate,
those who are moribund, comatose or where there are
clinical concerns that may preclude them being consid-
ered for inclusion.
Consent and recruitment procedure for people with
advanced dementia
We have obtained approval from a Research Ethics
Committee specialised in considering research on adults
2 Jones L, Harrington J, Scott S, et al. BMJ Open 2012;2:e002265. doi:10.1136/bmjopen-2012-002265
CoMPASs:IOn programme: protocol for a mixed methods study
 group.bmj.com on March 13, 2014 - Published by bmjopen.bmj.comDownloaded from 
who lack capacity. We shall gain assent from the
next-of-kin, unpaid carer or close person to act as a ‘per-
sonal consultee’ according to the Mental Capacity Act
(UK) 2005. If no ‘personal consultee’ is available the
research team will nominate a clinician to act in this cap-
acity as a ‘professional consultee’, deﬁned according to
current guidance9 as a ‘professional who is not directly
involved in the research or the care of the person with
dementia’. To ensure collection of maximum data, con-
sultees will be asked for consent for the research team
to access health and social care records across primary
and secondary care. We have used similar processes in
earlier work funded by the Alzheimer’s Society and
BUPA Foundation (BePaid grant ref. 131).24
Data collection
We will collect demographic information at baseline
including information obtained from GP notes such as
medications; acute hospital admissions and the reasons
for these; and ‘sentinel events’, deﬁned as ‘new medical
conditions that have the potential to lead to a signiﬁcant
change in health status and a shift in the goals of care’,
for example, pneumonia and hip fracture.17 The sources
of data are summarised in table 1. Patients will be
reviewed every 4 weeks for a maximum of 9 months or
until death. We will document the presence of advance
directives, care plans and speciﬁc requests regarding
hospitalisation and resuscitation.9
Health economics
We will calculate costs for the last 6 months of life. We
will combine the volume of resource use data obtained
for people with advanced dementia and their carers
with unit costs data from published sources37 38 in order
to calculate costs per patient from NHS, personal social
services and societal perspectives.
Data analysis
Interim descriptive analyses will be conducted at 6, 12
and 24 weeks which will inform our understanding of
patient outcomes, symptom burden, mortality, patient
pathways, case studies and scenarios. After full data col-
lection, we shall present the cohort demographics, the
symptoms experienced and calculate symptom rates over
the follow-up period (with CIs), taking into account
repeated measures. We shall explore the level and
nature of unmet needs, describing how comfort and
quality of life change over time and differences between
those living in care homes and those remaining in their
own homes.
Sample size
Numbers are chosen pragmatically, guided by the litera-
ture,17 and the anticipated feasibility of recruitment
rates and survival times of people at FAST stage 7c.
Figure 1 The Care Of Memory
Problems in Advanced Stages:
Improving Our Knowledge
programme, first phase.
Jones L, Harrington J, Scott S, et al. BMJ Open 2012;2:e002265. doi:10.1136/bmjopen-2012-002265 3
CoMPASs:IOn programme: protocol for a mixed methods study
 group.bmj.com on March 13, 2014 - Published by bmjopen.bmj.comDownloaded from 
Informal carers
Study population, consent and recruitment procedures
We will recruit 50 informal carers of people with
advanced dementia, deﬁned as unpaid informal carer
(eg, family member or friend in regular contact and
who is the next of kin or a ‘key decision maker’). They
will require English language sufﬁcient to complete the
study ratings. We will exclude carers where there are
clinical concerns that may preclude them being
approached. Carers will be informed that some patient
and carer experiences may be used to generate patient
pathways, case studies or scenarios. Carers will be invited
to take part when approached about considering the
participation of their relative of friend in the patient
cohort study. They will give informed consent according
to usual ethics procedures.
Assessments
We shall collect data during face-to-face interviews at
baseline and every 4 weeks by post or over the tele-
phone. At baseline we shall collect demographic data
including relationship to the person with dementia, the
number of years spent caring and any other caring
responsibilities. All other carer assessments are sum-
marised in table 2.
Data collection in bereavement
If the patient dies, carers will be interviewed in a place
of their choice at 7 months post-bereavement to con-
sider complicated grief which requires 6 months of
symptoms, using the Inventory for Complicated Grief.43
If complicated grief is identiﬁed, participants will be sup-
ported to access appropriate services. We shall under-
take interviews which we will analyse using qualitative
methods, to gain a deeper understanding of the circum-
stances surrounding the death and the views of the carer
on which aspects of care were or were not satisfactory.
Data analysis
We shall describe the demographic characteristics of
carers and their well-being at study entry and explore
descriptively the trajectory of carer well-being in tandem
with patient data and how this changes if the person
with dementia dies. Data will include carer outcomes as
listed in table 2.
Table 1 Summary of assessments for people with advanced dementia
Measure/author Purpose Source*
Time of
assessment
Functional assessment staging scale
(FAST)16
Describes a continuum of seven stages of
functional impairment
2 Baseline
Diagnostic statistical manual of mental
disorders (DSM-1V)23
Diagnostic criteria for dementia 2 Baseline
Charlson co-morbidity index25 Calculates severity of chronic comorbidities 2 Baseline
Waterlow scale26 Risk for developing pressure sores 2,3 Baseline/monthly
Sterling wound assessment scale27 Assesses extent of wound damage 2,3 Baseline/monthly
Bedford Alzheimer nursing scale
(BANS)28
Used to stage levels of severe memory
impairment in dementia
2,3 Baseline/monthly
Confusion assessment measure
(CAM)29
Measures confusion and diagnoses delirium and
distinguishes between delirium and dementia
1,2,3,4 Baseline/monthly
The neuropsychiatric inventory (NPI)30 Assesses behavioural and psychological
symptoms in dementia
2,3,4 Baseline/monthly
Cohen Mansfield agitation inventory
(CMAI)31
Measures a range of agitated and potentially
challenging behaviours
2,3,4 Baseline/monthly
Pain assessment in advanced dementia
(PAINAD)32
Observational pain tool used to measures pain
during care tasks and at rest
1 Baseline/monthly
Symptom management at the end of life
in dementia scale (SM-EOLD)33
Assesses comfort and pain in the prior 30 days 1,2,3,4 Baseline/monthly
Quality of life in late stage dementia
scale (QUALID)34
Quality of life in the prior week 3,4 Baseline/monthly
Painful interventions Scale35 Lists painful interventions, eg,insertion of
nasogastric tube
2,3,4 Baseline/monthly/
post death
The resource utilisation in dementia
questionnaire (RUD-LITE)36
Formal and informal health and social care
resource use
2,3,4 Baseline/monthly/
post death
Client services receipt inventory
(CSRI)37
As above but more financially based 2,3,4 Baseline/monthly/
post death
Comfort assessment in dying
(CAD-EOLD)33
Comfort assessment in dying with dementia 2,3,4 Death
*1, Patient; 2, patient primary care records; 3, care home staff; 4, informal carer.
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Workshops and interactive interviews (qualitative data)
We shall hold an iterative cycle of workshops and inter-
active interviews with carers and healthcare professionals
to generate hypotheses on how end-of-life care for
people with advanced dementia and their carers might
be improved. Case studies, scenarios and examples of
patient pathways and carer experiences informed by
data from the cohort studies will be used to generate dis-
cussions. Data generated may challenge existing ideas
and will lead to the emergence of new theories for
further exploration. Themes explored at the workshops
will be revised as the study progresses.44 45
Workshops with health and social care professionals
Participants
We shall purposively recruit participants from a range of
statutory and private providers, and professionals from a
variety of disciplines for example, general practitioners,
district nurses, speech and language therapists, palliative
care specialist nurse/doctors, psychiatric nurses, psychia-
trists, geriatricians, Admiral nurses, ambulance staff,
social workers, care home staff and commissioners.
Potential participants will be sent a study information
sheet stating that they have been identiﬁed as a person
who currently or previously has shown interest in provid-
ing end of life are for people with severe memory pro-
blems and their carers. They will give informed consent
before taking part. Workshops will be facilitated by two
members of the research team. A total of 12 workshops
will take place over 6 months each with a maximum of
10 participants.
Location
To understand and consider regional variation in
resources, services, needs and policy we shall purposively
select providers and commissioners of health and social
care in primary, secondary and tertiary settings from
four areas of the UK (London, Belfast, Edinburgh and
Solihull).
Workshops with carers
Workshops will be conducted with past and present
informal carers of people with advanced dementia.
Recruitment and consent
To ensure our population is representative, carers of
people with advanced dementia will be recruited from
across London. Seventy per cent of people with
advanced dementia reside in care homes and 30% at
home and we shall stratify our sample to reﬂect this.
Carers will be acting in an unpaid informal role and will
be identiﬁed by GP linked to the PCRN or by care
home managers.
Inclusion criteria
Those eligible for inclusion will be main informal carers
of people with advanced dementia (eg, family member
or friend in regular contact who is either next of kin or
a ‘key decision maker’) with English language skills sufﬁ-
cient to participate in workshops or interactive inter-
views. We shall not include carers under the age of 16 or
those for whom there are clinical concerns that may pre-
clude them from being approached such as severe phys-
ical or mental illness or lack of capacity to give informed
consent.
Workshops with people with early stage dementia
We shall conduct up to two workshops with people with
early dementia.
Table 2 Summary of assessments for carers
Measure/author Purpose Source* Time of assessment
Brief COPE39 Measures coping strategies used 4 Baseline
Zarit burden interview40 Reflects feelings about caring, measures
carer burden
4 Baseline/monthly
Short form 12 health survey
questionnaire (SF-12)41
Measures health related quality of life over
eight domains
4 Baseline/monthly/2 and
7 months postdeath
Hospital anxiety and depression scale
(HADS)42
Anxiety and depression 4 Baseline/monthly/2 and
7 months postdeath
Inventory of complicated grief (ICG)
pre-loss43
Assesses prevalence and severity of
carers’ anticipatory grief
4 Baseline
Inventory of complicated grief (ICG)
pre-loss (ICG-R) postloss43
Identifies symptoms of complicated grief 4 2 and 7 months post death
The resource utilization in dementia
questionnaire (RUD-LITE)36
Formal and informal health and social
care resource use
4 Baseline/monthly/2 months
postdeath
Client services receipt Inventory
(CSRI)37
As above but more financially based 4 Baseline/monthly/2 months
postdeath
Satisfaction with care at the end of life
(SWC/CAD-EOLD)33
Assesses the carers’ level of satisfaction
with care in advanced dementia
4 Baseline/monthly/2 months
postdeath
*4, Informal carer.
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Recruitment and consent
People with early stage dementia who have a Mini Mental
State Examination46 of 20 and above and who are under
the care of a specialist memory clinic will be recruited to
participate in workshops using the North Thames
DeNDRoN research register (DemReg), a database of
patients from memory clinics and old age psychiatry ser-
vices who have given signed consent to be approached to
participate in research studies. We will not include
people if there are clinical concerns precluding them
from being approached, those who lack capacity to
consent at the outset and those who are unable to com-
municate in English to a degree whereby they would be
unable to participate in the workshops. Using a four-
point framework (Mental Capacity Act, 2005; p45), the
researcher will make an independent assessment of the
capacity of the person with dementia at the point of
recruitment. To participate, they will be able to: (1)
understand (relevant) information about the decision to
be made; (2) retain this; (3) use or weigh the informa-
tion as part of the decision-making process and (4)
communicate their decision.
Data analysis
One researcher will take detailed ﬁeld notes during the
workshops to record the setting, the activities that took
place, who participated and their role in the activities
and exact quotations or close approximations of import-
ant comments made. We shall use ﬂip-charts to record
key elements of discussions. All data will be entered into
a qualitative software programme, Atlas-ti and analysed
for thematic content emphasising emerging hypotheses
on how care may be improved.
Interviews with carers and healthcare professionals
Unstructured interactive interviews are appropriate for
understanding complex issues that are relevant to
healthcare settings.47 Such interviews provide partici-
pants considerable control over the interview process48
and are similar to guided conversations.47 We shall
conduct individual interactive interviews with carers and
healthcare professionals. As with the workshops, discus-
sions will be facilitated using case studies and scenarios
of patient and carer experience. These interactive inter-
views take an account of the natural interaction between
researcher and participant through which each uncon-
sciously considers underlying hypotheses and contextua-
lises responses. Our approach will be underpinned by
critical realism attempting to uncover inﬂuential pro-
cesses, policies, perceptions and events that often deter-
mine health and social care outcomes. A maximum of
10 interviews will occur only in London at 8, 14 and
30 weeks from the start of the cohort studies, giving
30 interviews with healthcare professionals and 30 inter-
views with carers. Themes explored during the inter-
views will be revised as the study progresses.
Health and social care professionals
As with the workshops, interviews will be conducted with
a wide range of health and social care professionals to
provide an overall perspective. Topics may include dis-
cussion about health and social care professionals’ roles
and responsibilities for patients with advanced dementia.
We shall explore what they perceive as the good and bad
things about their role and their relationships with other
professionals in the ﬁeld. This will lead to discussions
about what an ideal model of care would look like, how
this compares with what actually happens now and how
improvements might be achieved. We shall also explore
how people respond to things that go wrong in everyday
practice.
Carers
Interviews will be conducted with current and past
carers of people with advanced dementia. We shall
explore in depth the complex and potentially contested
layers of patient and carer experience and how changes
in the management of advanced dementia could
improve care pathways. More speciﬁcally, topics may
include illness beliefs and the illness journey, carer
needs along the journey, communication and informa-
tion needs, the carers’ role in decision making, attitudes
towards end-of-life care and palliative care principles.
Data analysis
Interviews will be audio-taped, transcribed verbatim and
entered into Atlas-ti. The transcripts will be combined
with ﬁeld notes, memos and any relevant policy docu-
ments to reﬂect upon our initial hypotheses. Thus, we
shall identify and clarify the barriers to the provision of
good health and social care by revealing underlying,
often unseen, factors and processes. With the support of
diagrams and charts, the analysis will detail and explain
the complex linkages between actors and agencies, struc-
tural and cultural factors. We shall explore the best way
of providing a clear description of key issues that can be
fully appreciated by a range of professionals and carers.
For example, while we shall undertake a thematic ana-
lysis of the data we shall also seek to describe particular
barriers through a revision of the case studies and vign-
ettes in a way that accommodates the new explanatory
information in an accessible way. While we shall look for
patterns or commonalities of behaviour and events we
shall also examine and explain irregular cases. The ana-
lysis and ﬁndings will allow us to build a comprehensive
set of recommendations to be incorporated within the
development of our intervention. This will also stand
alone as a signiﬁcant contribution to the evidence base
of end-of-life care.
Patient and public involvement
We are experienced in involving people with dementia
and their relatives in research.49 50 We shall involve
people with early dementia, carers are included in
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workshops across the UK and an expert by experience
joins our steering group.
Expert steering group
An expert steering group will meet three times per year.
The group is composed of stakeholders with expertise in
end-of-life care and dementia including service provi-
ders and policy makers from statutory and voluntary
bodies. The group will monitor the progress of the
research, review interim ﬁndings and ensure the appro-
priate media and policy proﬁle of the work as it unfolds.
ETHICS AND DISSEMINATION
We have obtained approval from NHS ethical commit-
tees through IRAS for studies involving people with
dementia and carers (cohort studies REC ref. 12/EE/
0003; workshops and interactive interviews REC ref. 12/
LO/0346), and from university ethics committees for
work with health and social care professionals (REC ref.
3578/001).
We shall prepare documents for dissemination by
end-of-life and dementia care organisations such as
Marie Curie Cancer Care, BUPA, Dementia UK, The
Alzheimer’s Society, National Council for Palliative Care,
National End of Life Care programme and the govern-
ment special advisor for dementia including detailed
reports, scientiﬁc presentations at conferences and
papers for peer reviewed journals, and publicise our ﬁnd-
ings on the Marie Curie website. A summary will be pro-
vided to all participants who would like to receive this.
DISCUSSION
Combining the quantitative and qualitative data from
this study will enable us to gain a greater and more
detailed understanding of the clinical and social care
needs of people with advanced dementia and their
carers as they face death, and for carers into bereave-
ment. Data will inform explanations of the barriers to
good care and generate hypotheses on how these can be
challenged in new ways to provide innovative solutions.
We shall be able to report in detail on the clinical
symptom burden of people with advanced dementia
living in care homes and their own homes and on their
survival. We will gain an in-depth understanding of the
complex interactions between the patient experience of
care, the involvement of carers and the health and
social care systems in which care is delivered and
received.45 Our mixed methods in-depth approach will
enable us to consider factors that might affect the imple-
mentation of an intervention from the outset.51 52
Further work
We have received funding from Marie Curie Cancer Care
for subsequent research in which we shall use these data
to inform the development of a complex intervention.
We shall collect data on its acceptability, feasibility and
potential costs by piloting the intervention in one
healthcare economy before proceeding to further testing
in an exploratory randomised controlled trial.
Strengths and limitations
While there have been some prospective cohort studies
in other countries53 to our knowledge our quantitative
data will be the ﬁrst of this nature to be collected in the
UK population. We are attempting to ensure that we
recruit a representative sample of people with advanced
dementia and their family carers, and have used profes-
sional consultees so that people with advanced dementia
who may not have a relative to assent for them can still
be included in research. Using qualitative research
methods will provide a richness and background to this
quantitative data, allowing it to be better placed in the
context of a complex health and social care system.
While dementia is a terminal disease in its own right,
our research does not address the palliative and
end-of-life care needs of those dying at earlier stages of
dementia from other conditions.
CONCLUSION
We know that as the numbers dying with dementia con-
tinue to increase, this programme will be of importance
to health and social care service planners. The analysis
and ﬁndings will allow us to build a comprehensive set
of recommendations to be incorporated within the
development of our complex intervention. Policy in this
ﬁeld is rapidly developing and we shall report ﬁndings
as soon as they are available to ensure that the insights
we gain enter the public domain as quickly as possible.
Contributors LJ and ELS devised the programme of research and secured the
funding; LJ, ELS, SS and JH wrote the study protocols. LJ, ELS and JH
drafted the manuscript. All authors critically revised the manuscript for
important intellectual content. All authors read and approved the final
manuscript.
Funding This programme of research has been fully funded by Marie Curie
Cancer Care (grant ref. MCCC-FPR-11-U) through a process administered in
partnership with Cancer Research UK.
Competing interests None.
Ethics approval NHS Ethics Comittees and UCL Ethics Committee.
Provenance and peer review Not commissioned; internally peer reviewed.
REFERENCES
1. Knapp M, Prince M, Albanese E, et al. Dementia UK, Alzheimer’s
Society, London. 2007. http://www.alzheimers.org.uk/site/scripts/
download.php?fileID=2 (accessed Oct 2012).
2. Brayne C, Gao L, Dewey M, et al. Dementia before death in ageing
societies-the promise of prevention and the reality. PLoS Med
2006;10:e397.
3. Dewey ME, Saz P. Dementia, cognitive impairment and mortality in
persons aged 65 and over living in the community: a systematic
review of the literature. Int J Geriatr Psychiatry 2001;16:751–61.
4. Sampson EL, Bulpitt CJ, Fletcher AE. Survival of community-dwelling
older people: the effect of cognitive impairment and social engagement.
J Am Geriatr Soc 2009;57:985–91.
5. Sampson EL, Gould V, Lee D, et al. Differences in care received by
patients with and without dementia who died during acute hospital
admission: a retrospective case note study. Age Ageing
2006;35:187–9.
Jones L, Harrington J, Scott S, et al. BMJ Open 2012;2:e002265. doi:10.1136/bmjopen-2012-002265 7
CoMPASs:IOn programme: protocol for a mixed methods study
 group.bmj.com on March 13, 2014 - Published by bmjopen.bmj.comDownloaded from 
6. Davies E, Higginson IJ. Better palliative care for older people.
Copenhagen: World Health Organisation Europe, 2004. http://www.
euro.who.int/__data/assets/pdf_file/0009/98235/E82933.pdf
(accessed Oct 2012).
7. Sanders S, Swails P. Caring for individuals with end-stage dementia
at the end of life. Dementia 2009;8:117–38.
8. McCarty CE, Volicer L. Hospice access for individuals with
dementia. Am J Alzheimers Dis Other Demen 2009;24:476–85.
9. Department of Health. End of life care strategy: promoting high
quality care for all adults at the end of life. London: Department of
Health, 2008.
10. Bourne J. Improving services and support for people with dementia.
London: National Audit Office, 2007. http://www.nao.org.uk/
publications/0607/support_for_people_with_dement.aspx (accessed
Oct 2012).
11. Sampson EL, Ritchie CW, Lai R, et al. A systematic review of the
scientific evidence for the efficacy of a palliative care approach in
advanced dementia. Int Psychogeriatr 2005;17:31–40.
12. Goodman C, Evans C, Wilcock J, et al. End of life care for
community dwelling older people with dementia: an integrated
review. Int J Geriatr Psychiatry 2010;25:329–37.
13. Jordan A. Extending palliative care to people with dementia. Br J
Hosp Med (Lond) 2010;71:31–5.
14. Campbell ML, Dove-Medows E, Walch J, et al. The impact of
multidisciplinary educational intervention to reduce PEG tube
placement in patients with terminal-stage dementia: a translation of
research into practice. J Palliat Med 2011;14:1017–21.
15. Hanson LC, Carey TS, Caprio AJ, et al. Improving decision-making
for feeding options in advanced dementia: a randomized, controlled
trial. J Am Geriat Soc 2011;59:2009–16.
16. Reisberg B. Functional assessment staging (FAST). Psychopharmacol
Bull 1988;24:653–9.
17. Mitchell SL, Teno JM, Kiely DK, et al. The clinical course of
advanced dementia. N Engl J Med 2009;361:1529–38.
18. McCarthy M, Addington-Hall J, Altmann D. The experience of dying
with dementia: a retrospective study. Int J Geriatr Psychiatry
1997;12:404–9.
19. The coalition. Our programme for government. London: Cabinet
Office, 2010. http://www.cabinetoffice.gov.uk/news/
coalition-our-programme-government (accessed Oct 2012).
20. Department of Health. Prime Minister’s challenge on dementia.
Delivering major improvements in dementia care and research by
2015. London: Department of Health, 2012. http://www.dh.gov.uk/
health/2012/03/pm-dementia-challenge/ (accessed Oct 2012).
21. van der Steen JT. Dying with dementia: what we know after more
than a decade of research. J Alzheimers Dis 2010;22:37–55.
22. Chan D, Livingston G, Jones L, et al. Grief reactions in dementia
caregivers: a systematic review. Int J Geriatr Psychiatry Published
online first: 8 March 2012. doi: 10.1002/gps.3795.
23. American Psychiatric Association. Diagnostic and statistical manual
of mental disorders (DSM-1V). Washington, DC: American
Psychiatric Association, 1994.
24. Scott S, Jones L, Blanchard MR, et al. Study protocol: the Behaviour
and Pain in Dementia Study (BePAID). BMC Geriatr 2011;16:61. http://
www.biomedcentral.com/1471-2318/11/61 (accessed Oct 2012).
25. Charlson ME. Studies of prognosis: progress and pitfalls. J Gen
Intern Med 1987;2:359–61.
26. Waterlow J. Pressure sores: a risk assessment card. Nurs Times
1985;81:49–55.
27. Reid J, Morison M. Classification of pressure sore severity. Nurs
Times 1994;90:46–50.
28. Volicer L, Hurley AC, Lathi DC, et al. Measurement of severity in
advanced Alzheimer’s disease. J Gerontol 1994;49:M223–6.
29. Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the
confusion assessment method. A new method for detection of
delirium. Ann Intern Med 1990;113:941–8.
30. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric
Inventory: comprehensive assessment of psychopathology in
dementia. Neurology 1994;44:2308–14.
31. Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of
agitation in a nursing home. J Gerontol 1989;44:M77–84.
32. Zwakhalen SM, Hamers JP, bu-Saad HH, et al. Pain in elderly
people with severe dementia: a systematic review of behavioural
pain assessment tools. BMC Geriatr 2006;6:3.
33. Kiely DK, Volicer L, Teno J, et al. The validity and reliability of scales
for the evaluation of end-of-life care in advanced dementia.
Alzheimer Dis Assoc Disord 2006;20:176–81.
34. Weiner MF, Martin-Cook K, Svetlik DA, et al. The quality of life in
late-stage dementia (QUALID) scale. J Am Med Dir Assoc
2000;1:114–16.
35. Morrison RS, Ahronheim JC, Morrison GR, et al. Pain and
discomfort associated with common hospital procedures and
experiences. J Pain Symptom Manage 1998;15:91–101.
36. Wimo A, Winblad B. Resource utilisation in dementia: RUD Lite.
Brain Aging 2003;3:48–59.
37. Beecham J, Knapp M. Costing psychiatric interventions. In:
Thornicroft G, ed. Measuring mental health needs. London: Gaskell,
2001:200–24.
38. Netten A, Curtis L. Unit costs of health and social care. Canterbury:
Personal Social Services and Research Unit, 2005.
39. Carver CS. You want to measure coping but your protocol’s too
long: consider the brief COPE. Int J Behav Med 1997;4:92–100.
40. Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired
elderly: correlates of feelings of burden. Gerontologist
1980;20:649–55.
41. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health
survey: construction of scales and preliminary tests of reliability and
validity. Med Care 1996;34:220–33.
42. Zigmond AS, Snaith RP. The hospital anxiety and depression scale.
Acta Psychiatr Scand 1983;67:361–70.
43. Prigerson HG, Maciejewski PK, Reynolds CF III, et al. Inventory of
Complicated Grief: a scale to measure maladaptive symptoms of
loss. Psychiatry Res 1995;59:65–79.
44. Sampson EL, Mandal U, Holman A, et al. Improving end of life care
for people with dementia: a rapid participatory appraisal. BMJ
Support Palliat Care 2012;2:108–14.
45. Harrison-Dening K, Greenish W, Jones L, et al. Barriers to providing
end of life care for people with dementia: a whole-system qualitative
study. BMJ Support and Palliat Care 2012;2:103–7.
46. Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A
practical method for grading the cognitive state of patients for the
clinician. J Psychiatr Res 1975;12:189–98.
47. DiCicc0-Bloom B, Crabtree BF. The qualitative research interview.
Med Educ 2006;40:314–21.
48. Corbin J, Morse JM. The unstructured interactive interview: issues of
reciprocity and risks when dealing with sensitive topics. Qual Inquiry
2003;9:335–54.
49. Livingston G, Leavey G, Manela M, et al. Making decisions for
people with dementia who lack capacity: qualitative study of family
carers in UK. BMJ 2010;341:c4184.
50. Dartington T, Coupe K, Malloy L, et al. Dying from dementia—a
patient’s journey. BMJ 2008;337:a1712.
51. Campbell M, Fitzpatrick R, Haines A, et al. Framework for design
and evaluation of complex interventions to improve health. BMJ
2000;321:694–6.
52. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating
complex interventions: the new Medical Research Council guidance.
BMJ 2008;337:979–83.
53. Mitchell SL, Kiely DK, Jones RN, et al. Advanced dementia in the
nursing home: the CASCADE study. Alzheimer Dis Assoc Disord
2006;20:166–75.
8 Jones L, Harrington J, Scott S, et al. BMJ Open 2012;2:e002265. doi:10.1136/bmjopen-2012-002265
CoMPASs:IOn programme: protocol for a mixed methods study
 group.bmj.com on March 13, 2014 - Published by bmjopen.bmj.comDownloaded from 
doi: 10.1136/bmjopen-2012-002265
 2012 2: BMJ Open
 
Louise Jones, Jane Harrington, Sharon Scott, et al.
 
mixed methods study
Improving Our Knowledge): protocol for a
Problems in Advanced Stages of dementia: 
CoMPASs: IOn programme (Care Of Memory
 http://bmjopen.bmj.com/content/2/6/e002265.full.html
Updated information and services can be found at: 
These include:
References
 http://bmjopen.bmj.com/content/2/6/e002265.full.html#ref-list-1
This article cites 43 articles, 11 of which can be accessed free at:
Open Access
http://creativecommons.org/licenses/by-nc/2.0/legalcode.
http://creativecommons.org/licenses/by-nc/2.0/ and 
compliance with the license. See:
work is properly cited, the use is non commercial and is otherwise in 
use, distribution, and reproduction in any medium, provided the original
Creative Commons Attribution Non-commercial License, which permits 
This is an open-access article distributed under the terms of the
service
Email alerting
the box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in
Collections
Topic
 (167 articles)Qualitative research   
 (17 articles)Palliative care   
 
Articles on similar topics can be found in the following collections
Notes
 http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
 http://journals.bmj.com/cgi/reprintform
To order reprints go to:
 http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
 group.bmj.com on March 13, 2014 - Published by bmjopen.bmj.comDownloaded from 
